Trials / Recruiting
RecruitingNCT07075276
Liquid Phase Concentrated Growth Factor Versus Conventional Arthrocentesis in Temporomandibular Disc Displacement
Injection of Liquid Phase Concentrated Growth Factor Versus Conventional Arthrocentesis in Management of Temporomandibular Disc Displacement: A Randomized Controlled Clinical Trial
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 32 (estimated)
- Sponsor
- Horus University · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This study aims to rigorously assess the effectiveness of LPCGF in the management of internal disc displacement in patients with TMD through a randomized clinical trial. By comparing LPCGF therapy with conventional arthrocentesis, this research looks to provide robust evidence on the efficacy, safety, and potential role of (LPCGF) as an alternative therapeutic choice for IDD.
Conditions
- Temporomandibular Disorders (TMD)
- Internal Derangement of the Tempromandibular Joint
- Anterior Disc Displacement
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Liquid Phase Concentrated Growth Factor | 16 patients with anterior disc displacement with or without reduction randomly allocated to be treated with injection of liquid phase concentrated growth factor |
| PROCEDURE | Conventional arthrocentesis | 16 patients with anterior disc displacement with or without reduction randomly allocated to be treated with conventional arthrocentesis |
Timeline
- Start date
- 2025-10-01
- Primary completion
- 2026-05-01
- Completion
- 2026-06-01
- First posted
- 2025-07-20
- Last updated
- 2026-03-11
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07075276. Inclusion in this directory is not an endorsement.